title: Response to: 'MBDA: what is it good for?' by Yazici et al.
authors.affiliation: Department of Medicine, The Karolinska Institute, Stockholm, Sweden.
authors.forename: Ronald
authors.initials: R
authors.lastname: van Vollenhoven
authors.affiliation: Department of Medicine, The Karolinska Institute, Stockholm, Sweden.
authors.forename: Karen
authors.initials: K
authors.lastname: Hambardzumyan
authors.affiliation: Department of Medicine, Crescendo Bioscience Inc., South San Francisco, California, USA.
authors.forename: David
authors.initials: D
authors.lastname: Chernoff
authors.affiliation: Department of Medicine, Crescendo Bioscience Inc., South San Francisco, California, USA.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Bolce
mesh_terms: D001172:Arthritis, Rheumatoid / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood*; D006801:Humans
chemical_list: D015415:Biomarkers
keywords: Adult Onset Still's Disease; Amyloidosis; Analgesics